Application 213252
- Type
- ANDA
- Sponsor
- ALEMBIC PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FENOFIBRATE | FENOFIBRATE | TABLET;ORAL | 54MG | No | No |
| 002 | FENOFIBRATE | FENOFIBRATE | TABLET;ORAL | 160MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213252-001 | FENOFIBRATE | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | ||
| A213252-002 | FENOFIBRATE | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-03-09 01:35 UTC | 2022-03 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2020-01-17 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2020-01-17 | c0c555d07b60… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213252-001 | FENOFIBRATE | 54MG | TABLET / ORAL | 2020-01-17 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213252-002 | FENOFIBRATE | 160MG | TABLET / ORAL | 2020-01-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2020-11-12 02:37 UTC | 2020-11 | A213252-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A213252-002 | AB | 1 | c0c555d07b60… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fenofibrate | FENOFIBRATE | Alembic Pharmaceuticals Limited | 65ca643c-3b31-4e53-bc06-0e11418baf7d | 2023-01-30 | Warnings, Adverse reactions | 213252 ANDA213252 46708-351 46708-350 |
| Fenofibrate | FENOFIBRATE | Alembic Pharmaceuticals Inc. | 1e56492f-e2b1-4a07-b697-b59b3a0ac05e | 2021-02-24 | Warnings, Adverse reactions | 213252 ANDA213252 62332-350 62332-351 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 46708-350 | Fenofibrate | Fenofibrate | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-351 | Fenofibrate | Fenofibrate | Alembic Pharmaceuticals Limited | ANDA | Current |
| 62332-350 | Fenofibrate | Fenofibrate | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-350 | Fenofibrate | Fenofibrate | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-351 | Fenofibrate | Fenofibrate | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-351 | Fenofibrate | Fenofibrate | Alembic Pharmaceuticals Inc. | ANDA | Current |